Azalanstat

This classification denotes an anti-lipidemic agent with the molecular formula C22H24CLN3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 2NL79NI1WS chemically known as 1-(((2s,4s)-4-(((p-aminophenyl)thio)methyl)-2-(p-chlorophenethyl)-1,3-dioxolan-2-yl)methyl)imidazole, but more commonly known as azalanstat, which bears US NIH Compound Identifier 60876. European Medicines Agency schedules Azalanstat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05630MIG. The term AZALANSTAT is an International Non-Proprietary Name or INN. Most nations, for tariff and trade purposes, schedule azalanstat under HS 29349990 and SITC 51579. As of Q4 2014, AZALANSTAT remains US FDA's Preferred Term for this commodity. Azalanstat bears US NLM identifiers UMLS ID C0218596 and NCI Concept Code C79817. SMILES: C1[C@H](O[C@@](O1)(CCC2=CC=C(C=C2)CL)CN3C=CN=C3)CSC4=CC=C(C=C4)N.